17 research outputs found
Molecular epidemiology and evolution of enterovirus A71 and genetic interactions with others enterovirus A species responsive of Hand-Foot and Mouth Disease
La maladie pied-main-bouche (PMB) et lâherpangine sont deux maladies pĂ©diatriques bĂ©nignes causĂ©es par les entĂ©rovirus (EV), en particulier les sĂ©rotypes de lâespĂšce A (EV-A). Le sĂ©rotype EV-A71 fait lâobjet dâune surveillance dans les pays du Sud Est de lâAsie car il est associĂ© Ă des atteintes neurologiques sĂ©vĂšres chez les trĂšs jeunes enfants, parfois mortelles (dĂ©faillance cardio-pulmonaire). Les infections causĂ©es par les autres EV-A tel que le coxsackievirus A16 (CV-A16) provoquent rarement des atteintes sĂ©vĂšres. En Europe, les cas de maladie PMB causĂ©s par lâEV-A71 ne font pas lâobjet dâune dĂ©claration obligatoire, car ce virus ne cause pas dâĂ©pidĂ©mies de grande ampleur. Lâobjectif gĂ©nĂ©ral de la thĂšse Ă©tait dâĂ©tudier lâĂ©pidĂ©miologie des EV-A en Europe et nous avons utilisĂ© une approche phylogĂ©nĂ©tique bayĂ©sienne pour analyser un Ă©chantillon de 500 souches. Nous montrons la circulation discontinue de lâEV-A71 de deux populations virales principales (sous gĂ©nogroupes C1 et C2), ce qui explique la raretĂ© des Ă©pidĂ©mies en Europe. LâĂ©pidĂ©miologie de ce virus est aussi caractĂ©risĂ©e par des transports de souches entre les pays EuropĂ©ens et sporadiquement entre lâEurope et lâAsie (sous gĂ©nogroupes B5 et C4). La recombinaison gĂ©nĂ©tique intertypique survient rarement parmi les populations dâEV-A71 en circulation et ne contribue pas significativement Ă leur diversitĂ© gĂ©nĂ©tique. Cependant, ce mĂ©canisme gĂ©nĂ©tique est reliĂ© Ă lâĂ©mergence dâun sous gĂ©nogroupe CV-A16 qui circule en France depuis 2011. ComparĂ©s Ă lâEV-A71, les sĂ©rotypes CV-A2, CV-A4, CV-A6 sont plus frĂ©quemment sujets Ă des Ă©vĂ©nements de recombinaison intertypiques. Lâanalyse de la sĂ©lection Ă lâĂ©chelle molĂ©culaire indique que la fixation des mutations dans les protĂ©ines de capside de lâEV-A71 est lente, probablement Ă cause des contraintes structurales et fonctionnelles. La surveillance des infections Ă EV-A71 en Europe devrait ĂȘtre renforcĂ©e Ă cause de la neurovirulence de ce virus, de lâintroduction rĂ©cente et rĂ©pĂ©tĂ©e de souches variantes « asiatiques » et de lâexistence dâune grande diversitĂ© de gĂ©nogroupes en Afrique et en Inde encore peu explorĂ©e.Hand-Foot and Mouth Disease (HFMD) and Herpangina are two benign pediatric diseases caused by Enteroviruses (EV), especially enterovirus A species serotypes (EV-A). Infections caused by the EV-A71 serotype are monitored in countries of South East Asia because they are associated with severe neurological symptoms in young children and may be fatal (cardiopulmonary failure). Infections caused by the other EV-A serotypes, e.g. coxsackievirus A16 (CV-A16), rarely induce severe symptoms. In Europe, EV-A71 HFMD cases are not notifiable because this virus does not cause large-scale epidemics. The overall objective of this thesis was to study the EV-A epidemiology in Europe and we used a Bayesian phylogenetic approach to analyze 500 viral strains. We show a discontinued circulation of two EV-A71 populations (C1 and C2 subgenogroups), which explains the rare outbreaks in Europe. The epidemiology of this virus is characterized by transportation events of viral strains between European countries and sporadically between Europe and Asia (C4 and B5 subgenogroups). Intertypic genetic recombination occur rarely among circulating EV-A71 populations and does not contribute significantly to their genetic diversity. We found that genetic mechanism was related to the emergence of a new CV-A16 subgenogroup, which is circulating in France since 2011. In comparison with EV-A71, a number of serotypes (CV-A2, CV-A4, and CV-A6) are more frequently involved in intertypic recombination events. The structural and functional constraints are possible factors involved in the slow mutation fixation in the EV-A71 capsid proteins as determined by analyses of molecular selection. Neurovirulence, the recent and repeated introductions of variants âAsianâ strains, and the diversity of genogroups in Africa and India call for strengthened surveillance of EV-A71 infections among European countries
Epidémiologie moléculaire et évolution de l'entérovirus A71 et interactions génétiques avec les autres entérovirus de l'espÚce A responsables de la maladie pied-main-bouche.
Hand-Foot and Mouth Disease (HFMD) and Herpangina are two benign pediatric diseases caused by Enteroviruses (EV), especially enterovirus A species serotypes (EV-A). Infections caused by the EV-A71 serotype are monitored in countries of South East Asia because they are associated with severe neurological symptoms in young children and may be fatal (cardiopulmonary failure). Infections caused by the other EV-A serotypes, e.g. coxsackievirus A16 (CV-A16), rarely induce severe symptoms. In Europe, EV-A71 HFMD cases are not notifiable because this virus does not cause large-scale epidemics. The overall objective of this thesis was to study the EV-A epidemiology in Europe and we used a Bayesian phylogenetic approach to analyze 500 viral strains. We show a discontinued circulation of two EV-A71 populations (C1 and C2 subgenogroups), which explains the rare outbreaks in Europe. The epidemiology of this virus is characterized by transportation events of viral strains between European countries and sporadically between Europe and Asia (C4 and B5 subgenogroups). Intertypic genetic recombination occur rarely among circulating EV-A71 populations and does not contribute significantly to their genetic diversity. We found that genetic mechanism was related to the emergence of a new CV-A16 subgenogroup, which is circulating in France since 2011. In comparison with EV-A71, a number of serotypes (CV-A2, CV-A4, and CV-A6) are more frequently involved in intertypic recombination events. The structural and functional constraints are possible factors involved in the slow mutation fixation in the EV-A71 capsid proteins as determined by analyses of molecular selection. Neurovirulence, the recent and repeated introductions of variants âAsianâ strains, and the diversity of genogroups in Africa and India call for strengthened surveillance of EV-A71 infections among European countries.La maladie pied-main-bouche (PMB) et lâherpangine sont deux maladies pĂ©diatriques bĂ©nignes causĂ©es par les entĂ©rovirus (EV), en particulier les sĂ©rotypes de lâespĂšce A (EV-A). Le sĂ©rotype EV-A71 fait lâobjet dâune surveillance dans les pays du Sud Est de lâAsie car il est associĂ© Ă des atteintes neurologiques sĂ©vĂšres chez les trĂšs jeunes enfants, parfois mortelles (dĂ©faillance cardio-pulmonaire). Les infections causĂ©es par les autres EV-A tel que le coxsackievirus A16 (CV-A16) provoquent rarement des atteintes sĂ©vĂšres. En Europe, les cas de maladie PMB causĂ©s par lâEV-A71 ne font pas lâobjet dâune dĂ©claration obligatoire, car ce virus ne cause pas dâĂ©pidĂ©mies de grande ampleur. Lâobjectif gĂ©nĂ©ral de la thĂšse Ă©tait dâĂ©tudier lâĂ©pidĂ©miologie des EV-A en Europe et nous avons utilisĂ© une approche phylogĂ©nĂ©tique bayĂ©sienne pour analyser un Ă©chantillon de 500 souches. Nous montrons la circulation discontinue de lâEV-A71 de deux populations virales principales (sous gĂ©nogroupes C1 et C2), ce qui explique la raretĂ© des Ă©pidĂ©mies en Europe. LâĂ©pidĂ©miologie de ce virus est aussi caractĂ©risĂ©e par des transports de souches entre les pays EuropĂ©ens et sporadiquement entre lâEurope et lâAsie (sous gĂ©nogroupes B5 et C4). La recombinaison gĂ©nĂ©tique intertypique survient rarement parmi les populations dâEV-A71 en circulation et ne contribue pas significativement Ă leur diversitĂ© gĂ©nĂ©tique. Cependant, ce mĂ©canisme gĂ©nĂ©tique est reliĂ© Ă lâĂ©mergence dâun sous gĂ©nogroupe CV-A16 qui circule en France depuis 2011. ComparĂ©s Ă lâEV-A71, les sĂ©rotypes CV-A2, CV-A4, CV-A6 sont plus frĂ©quemment sujets Ă des Ă©vĂ©nements de recombinaison intertypiques. Lâanalyse de la sĂ©lection Ă lâĂ©chelle molĂ©culaire indique que la fixation des mutations dans les protĂ©ines de capside de lâEV-A71 est lente, probablement Ă cause des contraintes structurales et fonctionnelles. La surveillance des infections Ă EV-A71 en Europe devrait ĂȘtre renforcĂ©e Ă cause de la neurovirulence de ce virus, de lâintroduction rĂ©cente et rĂ©pĂ©tĂ©e de souches variantes « asiatiques » et de lâexistence dâune grande diversitĂ© de gĂ©nogroupes en Afrique et en Inde encore peu explorĂ©e
Thymus-specific serine protease, a protease that shapes the CD4 T cell repertoire
International audienc
Dynamique des microbiomes des voies respiratoires supérieures et inférieures associée à l'asthme sévÚre du nourrisson
International audienceThe human respiratory tract is colonized by microorganisms which constitute the respiratory microbiota. This microbiota is involved in the protection of the host against microbial infections. Its dynamics is regulated by mechanisms such as respiratory air flows, contributing to the inhalation of microorganisms, which is balanced by the host's immune system. An imbalance of these microbial communities, called dysbiosis, seems to be involved in the occurrence of respiratory pathologies such as asthma. This pathology affects about 25% of infants and its pathophysiology suggests a microbiota damage, associated with an inflammation. Major aims of this project are to characterize the global composition of the respiratory microbiome of infants with severe asthma, to follow its evolution over time and to determine the inflammatory profile of these patients. The cohort will include 100 patients from University Hospitals of Rouen and Caen. Nasopharyngeal and bronchoalveolar samples from these patients will be sequenced by metatranscriptomic approach and will allow to describe the respiratory microbiome composition. Inflammatory markers will also be analyzed through flow cytometry and ELISA to identify links between inflammation profiles involved in severe asthma and microbiome composition
"Microbiosthme" : Upper and lower airway microbiomes analysis in infants with severe asthma
International audienceThe human respiratory tract is colonized by microorganisms which constitute the respiratory microbiota. This microbiota is involved in the protection of the host against microbial infections. Its dynamics is regulated by mechanisms such as respiratory air flows, contributing to the inhalation of microorganisms, which is balanced by the host's immune system. An imbalance of these microbial communities, called dysbiosis, seems to be involved in the occurrence of respiratory pathologies such as asthma. This pathology affects about 25% of infants and its pathophysiology suggests a microbiota damage, associated with an inflammation. Major aims of this project are to characterize the global composition of the respiratory microbiome of infants with severe asthma, to follow its evolution over time and to determine the inflammatory profile of these patients. The cohort will include 100 patients from University Hospitals of Rouen and Caen. Nasopharyngeal and bronchoalveolar samples from these patients will be sequenced by metatranscriptomic approach and will allow to describe the respiratory microbiome composition. Inflammatory markers will also be analyzed through flow cytometry and ELISA to identify links between inflammation profiles involved in severe asthma and microbiome composition
Tissue-Specific Factors Differentially Regulate the Expression of Antigen-Processing Enzymes During Dendritic Cell Ontogeny
International audienceDendritic cells (DCs) form a collection of antigen-presenting cells (APCs) that are distributed throughout the body. Conventional DCs (cDCs), which include the cDC1 and cDC2 subsets, and plasmacytoid DCs (pDCs) constitute the two major ontogenically distinct DC populations. The pDCs complete their differentiation in the bone marrow (BM), whereas the cDC subsets derive from pre-committed BM precursors, the pre-cDC, that seed lymphoid and non-lymphoid tissues where they further differentiate into mature cDC1 and cDC2. Within different tissues, cDCs express distinct phenotype and function. Notably, cDCs in the thymus are exquisitely efficient at processing and presenting antigens in the class II pathway, whereas in the spleen they do so only upon maturation induced by danger signals. To appraise this functional heterogeneity, we examined the regulation of the expression of distinct antigen-processing enzymes during DC ontogeny. We analyzed the expression of cathepsin S (CTSS), cathepsin L (CTSL), and thymus-specific serine protease (TSSP), three major antigen-processing enzymes regulating class II presentation in cDC, by DC BM precursors and immature and mature cDCs from the spleen and thymus. We found that pre-cDCs in the BM express relatively high levels of these different proteases. Then, their expression is modulated in a tissue-specific and subset-specific manner with immature and mature thymic cDCs expressing overall higher levels than immature splenic cDCs. On the other hand, the TSSP expression level is selectively down-regulated in spleen pDCs, whereas CTSS and CTSL are both increased in thymic and splenic pDCs. Hence, tissue-specific factors program the expression levels of these different proteases during DC differentiation, thus conferring tissue-specific function to the different DC subsets
Etude préliminaire du microbiote urinaire bactérien de femmes non ménopausées
International audienc
Citrulline protects human retinal pigment epithelium from hydrogen peroxide and iron/ascorbate induced damages
International audienceAbstract Oxidative stress plays an important role in the ageing of the retina and in the pathogenesis of retinal diseases such as ageârelated macular degeneration (ARMD). Hydrogen peroxide is a reactive oxygen species generated by the photoâexcited lipofuscin that accumulates during ageing in the retinal pigment epithelium (RPE), and the ageârelated accumulation of lipofuscin is associated with ARMD. Iron also accumulates with age in the RPE that may contribute to ARMD as an important source of oxidative stress. The aim of this work was to investigate the effects of LâCitrulline (CIT), a naturally occurring amino acid with known antioxidant properties, on oxidative stressed cultured RPE cells. Human RPE (ARPEâ19) cells were exposed to hydrogen peroxide (H 2 O 2 ) or iron/ascorbate (I/A) for 4Â h, either in the presence of CIT or after 24Â h of pretreatment. Here, we show that supplementation with CIT protects ARPEâ19 cells against H 2 O 2 and I/A. CIT improves cell metabolic activity, decreases ROS production, limits lipid peroxidation, reduces cell death and attenuates ILâ8Â secretion. Our study evidences that CIT is able to protect human RPE cells from oxidative damage and suggests potential protective effect for the treatment of retinal diseases associated with oxidative stress
Enterovirus A71 Subgenotype B5, France, 2013
International audienceWe report the detection of human enterovirus A71 (EV-A71) subgenotype B5 in France, 6 years after it was first detected in Europ